DexCom, Inc.DXCM
NasdaqGS•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $4.82B, growing 16.1% year-over-year. TTM net income stood at $930.40M (73.8% growth). Quarterly EBITDA was $322.40M and operating income was $255.30M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze DXCM growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters